Logo of thoraxThoraxVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Thorax. 2005 Jul; 60(7): 570–575.
PMCID: PMC1747470

Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis


Background: Individuals with severely impaired lung function have an increased risk of lung cancer. Whether milder reductions in forced expiratory volume in 1 second (FEV1) also increase the risk of lung cancer is controversial. Moreover, there is little consensus on whether men and women have similar risks for lung cancer for similar decreases in FEV1.

Methods: A search was conducted of PubMed and EMBASE from January 1966 to January 2005 and studies that examined the relationship between FEV1 and lung cancer were identified. The search was limited to studies that were population based, employed a prospective design, were large in size ([gt-or-equal, slanted]5000 participants), and adjusted for cigarette smoking status.

Results: Twenty eight abstracts were identified, six of which did not report FEV1 and eight did not adjust for smoking. Included in this report are four studies that reported FEV1 in quintiles. The risk of lung cancer increased with decreasing FEV1. Compared with the highest quintile of FEV1 (>100% of predicted), the lowest quintile of FEV1 (<~70% of predicted) was associated with a 2.23 fold (95% confidence interval (CI) 1.73 to 2.86) increase in the risk for lung cancer in men and a 3.97 fold increase in women (95% CI 1.93 to 8.25). Even relatively small decrements in FEV1 (~90% of predicted) increased the risk for lung cancer by 30% in men (95% CI 1.05 to 1.62) and 2.64 fold in women (95% CI 1.30 to 5.31).

Conclusion: Reduced FEV1 is strongly associated with lung cancer. Even a relatively modest reduction in FEV1 is a significant predictor of lung cancer, especially among women.

Full Text

The Full Text of this article is available as a PDF (112K).

Supplementary Material

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ezzati Majid, Lopez Alan D. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003 Sep 13;362(9387):847–852. [PubMed]
  • Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002 Jan;38(1):99–166. [PubMed]
  • Jemal Ahmedin, Tiwari Ram C, Murray Taylor, Ghafoor Asma, Samuels Alicia, Ward Elizabeth, Feuer Eric J, Thun Michael J. Cancer statistics, 2004. CA Cancer J Clin. 2004 Jan-Feb;54(1):8–29. [PubMed]
  • Boffetta Paolo. Epidemiology of environmental and occupational cancer. Oncogene. 2004 Aug 23;23(38):6392–6403. [PubMed]
  • Gottschall E Brigitte. Occupational and environmental thoracic malignancies. J Thorac Imaging. 2002 Jul;17(3):189–197. [PubMed]
  • Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986 Oct;105(4):503–507. [PubMed]
  • Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987 Apr;106(4):512–518. [PubMed]
  • Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis. 1990 Mar;141(3):613–617. [PubMed]
  • Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996 Sep 21;313(7059):711–716. [PMC free article] [PubMed]
  • Kuller LH, Ockene J, Meilahn E, Svendsen KH. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Epidemiol. 1990 Aug;132(2):265–274. [PubMed]
  • Mannino David M, Aguayo Samuel M, Petty Thomas L, Redd Stephen C. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003 Jun 23;163(12):1475–1480. [PubMed]
  • Van den Eeden SK, Friedman GD. Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology. 1992 May;3(3):253–257. [PubMed]
  • Islam SS, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):289–298. [PubMed]
  • Nomura A, Stemmermann GN, Chyou PH, Marcus EB, Buist AS. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis. 1991 Aug;144(2):307–311. [PubMed]
  • Vestbo J, Knudsen KM, Rasmussen FV. Are respiratory symptoms and chronic airflow limitation really associated with an increased risk of respiratory cancer? Int J Epidemiol. 1991 Jun;20(2):375–378. [PubMed]
  • Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM, Higgins IT, Gray RG, Richards SM, Gilliland J, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis. 1983 Sep;128(3):491–500. [PubMed]
  • Wiles FJ, Hnizdo E. Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med. 1991 Jan;85(1):27–35. [PubMed]
  • Eberly Lynn E, Ockene Judith, Sherwin Roger, Yang Lingfeng, Kuller Lewis. Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. Int J Epidemiol. 2003 Aug;32(4):592–599. [PubMed]
  • Hogg James C, Chu Fanny, Utokaparch Soraya, Woods Ryan, Elliott W Mark, Buzatu Liliana, Cherniack Ruben M, Rogers Robert M, Sciurba Frank C, Coxson Harvey O, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004 Jun 24;350(26):2645–2653. [PubMed]
  • Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978 Jun 8;298(23):1277–1281. [PubMed]
  • Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001 Aug 16;345(7):517–525. [PubMed]
  • Ballaz Santiago, Mulshine James L. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003 Jul;5(1):46–62. [PubMed]
  • Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003 Oct;22(4):672–688. [PubMed]
  • Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect. 1993 Dec;101 (Suppl 5):35–44. [PMC free article] [PubMed]
  • Wodrich W, Volm M. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis. 1993 Jun;14(6):1121–1124. [PubMed]
  • Lee HJ, Im JG, Ahn JM, Yeon KM. Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings. J Comput Assist Tomogr. 1996 Nov-Dec;20(6):979–982. [PubMed]
  • Bouros Demosthenes, Hatzakis Kostas, Labrakis Haris, Zeibecoglou Kyriaki. Association of malignancy with diseases causing interstitial pulmonary changes. Chest. 2002 Apr;121(4):1278–1289. [PubMed]
  • Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993 Sep 1;138(5):281–293. [PubMed]
  • Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996 Feb 21;88(3-4):183–192. [PubMed]
  • Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993 Mar 17;85(6):457–464. [PubMed]
  • Bach Peter B, Kattan Michael W, Thornquist Mark D, Kris Mark G, Tate Ramsey C, Barnett Matt J, Hsieh Lillian J, Begg Colin B. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003 Mar 19;95(6):470–478. [PubMed]
  • Bain Chris, Feskanich Diane, Speizer Frank E, Thun Michael, Hertzmark Ellen, Rosner Bernard A, Colditz Graham A. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst. 2004 Jun 2;96(11):826–834. [PubMed]
  • Patel Jyoti D, Bach Peter B, Kris Mark G. Lung cancer in US women: a contemporary epidemic. JAMA. 2004 Apr 14;291(14):1763–1768. [PubMed]
  • Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001 Feb-Mar;31(2-3):139–148. [PubMed]
  • Nordquist Luke T, Simon George R, Cantor Alan, Alberts W Michael, Bepler Gerold. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004 Aug;126(2):347–351. [PubMed]
  • Jedrychowski W, Becher H, Wahrendorf J, Basa-Cierpialek Z, Gomola K. Effect of tobacco smoking on various histological types of lung cancer. J Cancer Res Clin Oncol. 1992;118(4):276–282. [PubMed]
  • Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 1996 Oct;17(10):2201–2205. [PubMed]
  • Toyooka Shinichi, Tsuda Toshihide, Gazdar Adi F. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat. 2003 Mar;21(3):229–239. [PubMed]
  • Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 1994 Nov 15;54(22):5801–5803. [PubMed]
  • Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 1999 Jul 15;59(14):3317–3320. [PubMed]
  • McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst. 1990 Aug 15;82(16):1333–1339. [PubMed]
  • Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol. 1991 Jul-Aug;4(4):391–407. [PubMed]
  • Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000 Nov 1;92(21):1764–1772. [PubMed]
  • Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 2004 Aug;59(8):679–681. [PMC free article] [PubMed]
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999 Jan;159(1):179–187. [PubMed]

Articles from Thorax are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...